Physician

Amber Janelle Oberle, M.D.

According to 2025 Medicare claims, Amber Oberle, M.D. (NPI: 1558653691) practices pulmonary disease in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Durham, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27705-2671. Oberle is affiliated with the Duke Connected Care, LLC (ACO ID: A2419), participating under the MSSP model.

Oberle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 316 traditional Medicare patients, billed 984 HCPCS/CPT codes, and received $58,141 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,592 prescription claims across 479 beneficiaries totaling $1,598,158 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 1,146 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $30,561 and ending at $58,141. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $7,009 to $1,598,158. For DME billing, reported payments moved sharply higher in recent years, from $1,022 to $110,429.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$34K$67K2017 Medicare payment: $30,561 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $51,539 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $67,123 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $30,723 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $52,026 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $49,152 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $49,637 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $58,141 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017133518$30,561
20182331,006$51,539
20193881,348$67,123
2020255625$30,723
2021299958$52,026
2022300897$49,152
2023307832$49,637
2024316984$58,141

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$905K$1.8M2015 Drug cost: $7,009 (USD; Tot_Drug_Cst)2016 Drug cost: $22,616 (USD; Tot_Drug_Cst)2017 Drug cost: $149,711 (USD; Tot_Drug_Cst)2018 Drug cost: $281,729 (USD; Tot_Drug_Cst)2019 Drug cost: $355,812 (USD; Tot_Drug_Cst)2020 Drug cost: $654,917 (USD; Tot_Drug_Cst)2021 Drug cost: $941,689 (USD; Tot_Drug_Cst)2022 Drug cost: $1,328,205 (USD; Tot_Drug_Cst)2023 Drug cost: $1,810,913 (USD; Tot_Drug_Cst)2024 Drug cost: $1,598,158 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152680$7,009
201631168$22,616
2017140594$149,711
20182101,089$281,729
20192181,088$355,812
20202291,222$654,917
20212611,668$941,689
20223192,025$1,328,205
20233952,577$1,810,913
20244792,592$1,598,158

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$83K$166K2017 Medicare payment: $9,785 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $30,884 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $30,460 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $62,857 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $122,046 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $165,709 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $146,913 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $141,967 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
20171592$9,785
201821317$30,884
201918328$30,460
202037409$62,857
2021103749$122,046
20221531,039$165,709
20231871,093$146,913
20242101,146$141,967

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more5858$153
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more8090$127
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more194256$82
95012Test to measure the level of nitric oxide gas5772$13
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's172226$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab732,548$358,439
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24914,910$309,619
Dupixent SyringeDupilumab351,232$165,859
Fasenra PenBenralizumab261,092$148,585
Breztri AerosphereBudesonide/Glycopyr/Formoterol874,590$95,718

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0466Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)YN/R39$49,846
E0483High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, eachYN/R32$29,000
J7677Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgramNN/R34$25,927
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY29240$17,632
J7626Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mgN2185$5,284

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Amber Janelle Oberle, M.D.?

Tedicare shows public-source Medicare data for Amber Janelle Oberle, M.D. (NPI 1558653691), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amber Janelle Oberle, M.D. have ACO affiliation data?

Amber Janelle Oberle, M.D. is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419).

What billing organization is linked to Amber Janelle Oberle, M.D.?

Amber Janelle Oberle, M.D. is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Amber Janelle Oberle, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.